(NEW YORK) -- New boosters for 5- to 11-year-olds are just weeks away from authorization, the vaccine chief at the Food and Drug Administration, Dr. Peter Marks, said Tuesday. While primary vaccines are already authorized for children 6 months and older, the FDA has yet... Read More.
(NEW YORK) -- After securing enough doses in the national stockpile to vaccinate the most at-risk Americans against monkeypox, the federal government says it has begun training its sights on the next steps of the outbreak. "We're watching this very, very closely and will be... Read More.
(NEW YORK) -- Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely distributed COVID vaccine developed by Pfizer and BioNTech, called Comirnaty, infringes... Read More.
(NEW YORK) -- Pfizer announced Thursday that its vaccine candidate for respiratory syncytial virus was more than 85% effective in preventing lower respiratory tract illness in older adults. The New York-based pharmaceutical company released findings from the Phase 3 clinical trial investigating its RSV vaccine... Read More.
(WASHINGTON) -- Some states and jurisdictions are hitting early bumps in their rollout of the U.S. government's new approach to expand access and supply of monkeypox vaccines to more at-risk Americans, local officials have told ABC News, as providers face a steep learning curve... Read More.
(WASHINGTON) -- Pfizer released new data Tuesday showing its vaccine continues to reduce the risk of COVID-19 in children ages six months to 4 years-old. Unlike Moderna's two-shot vaccine, Pfizer's vaccine is given as three initial doses for in this age group — considered a... Read More.
(NEW YORK) -- As demand for monkeypox vaccines increases, the World Health Organization (WHO) has begun to receive preliminary reports on the efficacy of the shots, which suggests there are breakthrough cases occurring, officials said Wednesday. "We have known from the beginning that this vaccine... Read More.
(NEW YORK) -- Since the monkeypox vaccine began being distributed in New York City, the rollout has been plagued with issues. The city's Department of Health and Mental Hygiene has cycled through several scheduling platforms in a matter of weeks, which have experienced crashes as... Read More.
(NEW YORK) -- On Monday, the U.K. became the first country to approve a bivalent vaccine booster shot for adults, which would target both the original COVID virus and the Omicron variant. This vaccine, which is likely going to be available in the U.S. starting... Read More.
(LONDON) — Children in London are being offered polio vaccine boosters after sewage samples with the virus were found in multiple areas across the city. The U.K. Health Security Agency announced Wednesday that all children between ages 1 and 9 across the British capital will be eligible... Read More.